How to read: Every bubble is one Indian sulfamethoxazole exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Sulfamethoxazole report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial sulfamethoxazole trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian sulfamethoxazole suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Sulfamethoxazole India trade report
P
Product scope
Sulfamethoxazole
All variants merged — branded and generic formulations of sulfamethoxazole
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
114
Every commercial sulfamethoxazole trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $343.3K, Nov $935.0K, Dec $245.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$343.3K
Oct USD
27 shipments
2
$935.0K
Nov USD
+172.4% MoM
3
$245.2K
Dec USD
-73.8% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 172.4% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $343K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MACLEODS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import sulfamethoxazole from India, how much they buy, and who supplies each market
KEY TAKEAWAYGeorgia absorbs 15.6% of India’s 2025-Q4 sulfamethoxazole trade ($237.9K). Beyond the top 10 destinations, 30 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 30 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much sulfamethoxazole India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$358K
23.5% of trade
7 countries · 26 shipments
Europe
$120K
7.9% of trade
4 countries · 15 shipments
Americas
$327K
21.4% of trade
5 countries · 14 shipments
Africa
$718K
47.2% of trade
16 countries · 59 shipments
Fig 4.1 Georgia is the #1 corridor ($238K) — 30 flow arcs from India radiate across 4 continents.
How to read: The world map shows every country colored by how much Indian sulfamethoxazole it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Georgia
$238K
3
MACLEODS PHARMACEUTICALS LTD
$238K
MILAN LABORATORIES (INDIA) PVT LTD
$0
—
—
2
Senegal
$172K
2
SIDHAANT LIFE SCIENCES PVT LTD
$172K
—
—
—
—
3
Kenya
$168K
7
MICRO LABS LTD
$121K
MEDICO REMEDIES LTD
$36K
AGOG PHARMA LTD
$11K
4
Mexico
$161K
8
J B CHEMICALS AND PHARMACEUTICALS LTD
$161K
—
—
—
—
5
Guatemala
$140K
2
CAPLIN POINT LABORATORIES LTD
$140K
—
—
—
—
6
Angola
$81K
10
VIDACARE MEDICA PVT LTD
$59K
SYNCOM FORMULATIONS (INDIA) LTD
$18K
SHALINA LABORATORIES PVT LTD
$3K
7
Nepal
$77K
8
ALKEM LABORATORIES LTD
$29K
LEGENCY REMEDIES PVT LTD
$21K
SUN PHARMACEUTICAL INDUSTRIES LTD
$17K
8
Cameroon
$71K
9
SURMOUNT LABORATORIES LTD
$33K
LILIUM INTERNATIONAL PVT LTD
$9K
DEVLIFE CORP PVT LTD
$8K
9
Tanzania
$51K
5
SCOTT EDIL PHARMACIA LTD
$35K
SHALINA LABORATORIES PVT LTD
$16K
—
—
10
Netherlands
$42K
4
MACLEODS PHARMACEUTICALS LTD
$32K
MICRO LABS LTD
$9K
3CUBE MEDICARE PVT LTD
$11
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 23.5% of USD — but Georgia is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
15.6%
#1 country share
Georgia alone
57.7%
Top 5 share
5 of 32 countries
90.2%
Top 15 share
Long tail of 17 countries = 9.8%
HHI 822
Destination HHI
Competitive spread
32
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
51 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYMACLEODS PHARMACEUTICALS LTD ($272.6K, 17.9% share) and SIDHAANT LIFE SCIENCES PVT LTD ($172.1K) together control 29.2% of India’s 2025-Q4 sulfamethoxazole trade. The top 5 suppliers hold 58.2%. 51 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian sulfamethoxazole suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MACLEODS PHARMACEUTICALS LTD leads by $101K over SIDHAANT LIFE SCIENCES PVT LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SYNCOM FORMULATIONS (INDIA) is #15 by value but #5 by volume.
Fig 5.2 J B CHEMICALS AND PHARMACEUTICALS LTD also leads by shipment count (8) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SYNCOM FORMULATIONS (INDIA) moves from #5 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 51 sulfamethoxazole suppliers split into strategic segments
KEY TAKEAWAY13 suppliers (25%) generate 79.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MACLEODS PHARMACEUTICALS LTD and SIDHAANT LIFE SCIENCES PVT LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 79.3% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
47 importers across 32 countries — who is buying Indian sulfamethoxazole and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 73.3% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian sulfamethoxazole. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 UNITED NATIONS CHILDRENS FUND is the #1 importer at $238K (15.6%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian sulfamethoxazole prices vary by supplier, country and dosage form
KEY TAKEAWAYSulfamethoxazole prices span 31017× ($0.0030 → $91.85). The coefficient of variation is 2.68. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MACLEODS PHARMACEUTICALS LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. J B CHEMICALSSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. CIRON DRUGS ANDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. SOMERSET THERAPEUTICS PVTSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
NORONIC PHARMACE…
Cameroon
Tablet
51
$7K
$133.26
Specialty / small-batch
Oct 2025
SYNCOM FORMULATI…
Cameroon
Tablet
70
$6K
$91.85
Specialty / small-batch
Nov 2025
SYNCOM FORMULATI…
Sierra Leone
Tablet
34
$3K
$88.27
Specialty / small-batch
Nov 2025
SYNCOM FORMULATI…
Sierra Leone
Tablet
1
$86.51
$86.51
Specialty / small-batch
Oct 2025
SYNMEX PHARMA PV…
DR Congo
Tablet
152
$12K
$80.08
Specialty / small-batch
Oct 2025
SYNMEX PHARMA PV…
DR Congo
Tablet
150
$12K
$79.46
Specialty / small-batch
Dec 2025
SYNCOM FORMULATI…
Angola
Tablet
239
$18K
$74.53
Specialty / small-batch
Dec 2025
SYNCOM FORMULATI…
Angola
Tablet
1
$29.81
$29.81
Specialty / small-batch
Nov 2025
SAI WORLD TRADE …
United Kingdom
concentrate
110
$3K
$29.18
Specialty / small-batch
Oct 2025
LILIUM INTERNATI…
Cameroon
Suspension
395
$9K
$23.03
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
S KANT HEALTHCAR…
Ethiopia
Suspension
20K
$58.04
$0.0030
Dec 2025
SHIVNAAM TRADELI…
United Arab Emirates
Tablet
2
$0.0068
$0.0034
Bulk generic tablet
Dec 2025
SAVORITE PHARMAC…
Cameroon
Suspension
25K
$86.00
$0.0035
Dec 2025
VIDACARE MEDICA …
DR Congo
Tablet
1.1M
$8K
$0.0071
Bulk generic tablet
Oct 2025
SURMOUNT LABORAT…
Cameroon
Tablet
4.0M
$33K
$0.0083
Bulk generic tablet
Nov 2025
VIDACARE MEDICA …
Angola
Tablet
5.0M
$42K
$0.0084
Bulk generic tablet
Oct 2025
VIDACARE MEDICA …
Angola
Tablet
2.0M
$17K
$0.0084
Bulk generic tablet
Oct 2025
BAL PHARMA LTD
Somalia
Tablet
783K
$7K
$0.0094
Bulk generic tablet
Dec 2025
SAVORITE PHARMAC…
Cameroon
Tablet
19K
$178.44
$0.0094
Bulk generic tablet
Dec 2025
SANGEETA PHARMA
Angola
Tablet
5K
$48.53
$0.010
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship sulfamethoxazole, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYSulfamethoxazole leaves India through 17+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), PATLI ICD, CHENNAI SEA) handle 90.4% of total USD. SEA moves 61% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $839K — top 17 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 61% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.1M
74.6% of USD · 60.5% of ships
ICD
$267K
17.5% of USD · 11.4% of ships
ROAD
$77K
5.1% of USD · 7.0% of ships
AIR
$42K
2.7% of USD · 21.1% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($336K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYMexico is the most concentrated destination (HHI 10000, 1 suppliers). Cameroon is the most competitive (HHI 2742).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Mexico (HHI 10,000) is the most concentrated — Cameroon (HHI 2,742) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
UNITED NATIONS CHILD…
Georgia
MACLEODS PHARMAC…
$238K
1
HIGH
P.N.A
Senegal
SIDHAANT LIFE SC…
$172K
2
HIGH
USAID/UGANDA
Kenya
MICRO LABS LTD
$121K
1
HIGH
LABORATORIOS JAYOR S.A
Mexico
J B CHEMICALS AN…
$81K
5
MEDIUM
LABORATORIOS JAYOR S…
Mexico
J B CHEMICALS AN…
$80K
3
MEDIUM
PRINCE FARMA SA
Angola
VIDACARE MEDICA …
$59K
2
MEDIUM
TO THE DIRECTOR
Tanzania
SCOTT EDIL PHARM…
$35K
2
MEDIUM
IMRES B.V
Netherlands
MACLEODS PHARMAC…
$32K
2
MEDIUM
Conclusion: 43 buyers depend on exactly one Indian supplier, representing $1.1M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Georgia
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Senegal
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Mexico
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Guatemala
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Angola
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Cameroon
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Netherlands
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
DR Congo
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Madagascar
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Denmark
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Mozambique
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Georgia
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit Mexico lock-ins (HHI 10000)
This Q
MED
A5
Enter Kenya (3 suppliers)
This Q
HIGH
A6
Enter Georgia (2 suppliers)
This Q
MED
A8
Build Senegal distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Kenya
Africa
3
$168K
+632.9%
LOW
Growing 633% with only 3 competitors
2
Georgia
Other
2
$238K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
3
Senegal
Africa
1
$172K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Mexico
Other
1
$161K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Guatemala
Other
1
$140K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Netherlands
Other
3
$42K
+199.8%
LOW
Growing 200% with only 3 competitors
7
Nepal
Asia
4
$77K
0%
LOW
Low competition (4 suppliers), accessible market
8
Tanzania
Africa
2
$51K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
DR Congo
Africa
3
$41K
-76%
LOW
Low competition (3 suppliers), accessible market
10
Madagascar
Africa
1
$39K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Denmark
Other
1
$35K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
France
Other
3
$30K
0%
LOW
Low competition (3 suppliers), accessible market
13
Mozambique
Africa
2
$28K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
14
Ethiopia
Africa
1
$27K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
United States
Other
1
$25K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 114 2025-Q4 Sulfamethoxazole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sulfamethoxazole
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 114 2025-Q4 sulfamethoxazole shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian sulfamethoxazole shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
114
across all regions
TOTAL USD
$1.52M
2025-Q4 FOB value
UNITS
34.7M
tablets, capsules, etc.
SUPPLIERS
51
Indian exporters
BUYERS
47
global importers
COUNTRIES
32
destinations
§10.2 Regional breakdown
Africa
$718K
47.2%
16 ctry · 59 ships
Asia
$358K
23.5%
7 ctry · 26 ships
Europe
$120K
7.9%
4 ctry · 15 ships
Americas
$327K
21.4%
5 ctry · 14 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $718K (47.2%), spanning 16 countries.
🏢
51 Indian suppliers shipped to 47 buyers across 32 countries — average shipment value $13K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 45 global sulfamethoxazole importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian sulfamethoxazole in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
UNITED NATIONS CHILDRENS FUND
Georgia
1
$238K
MACLEODS PHARMACEUTI…
Suspension
2
P.N.A
Senegal
2
$172K
SIDHAANT LIFE SCIENC…
Tablet, Suspension
3
USAID/UGANDA
Kenya
1
$121K
MICRO LABS LTD
Tablet
4
LABORATORIOS JAYOR S.A
Mexico
5
$81K
J B CHEMICALS AND PH…
Suspension, Infusion
5
LABORATORIOS JAYOR S.A. DE C.V
Mexico
3
$80K
J B CHEMICALS AND PH…
Suspension
6
PRINCE FARMA SA
Angola
2
$59K
VIDACARE MEDICA PVT …
Tablet
7
TO THE DIRECTOR
Tanzania
2
$35K
SCOTT EDIL PHARMACIA…
Tablet
8
IMRES B.V
Netherlands
2
$32K
MACLEODS PHARMACEUTI…
Suspension
9
PARTH PHARMA DISTRIBUTORS PVT LTD
Nepal
2
$29K
ALKEM LABORATORIES LTD
Dry Syrup, Drops
10
ACE HEALTH CARE LDA
Mozambique
1
$27K
BIOMATRIX HEALTHCARE…
Suspension
11
SHALINA HEALTHCARE SARL
DR Congo
4
$26K
SHALINA LABORATORIES…
Tablet, Suspension
12
RX CROSSROADS 3PL LLC
United States
1
$25K
SOMERSET THERAPEUTIC…
Injection
13
MEDICO PLUS
DR Congo
2
$24K
SYNMEX PHARMA PVT LTD
Tablet
14
HUMAN LIFE SCIENCE PVT LTD
Nepal
2
$21K
LEGENCY REMEDIES PVT…
resupplies
15
EURIMAX PHARMA
France
2
$19K
DEVATS INDIA PVT LTD
Tablet
16
HARLEYS LTD
Kenya
2
$18K
MEDICO REMEDIES LTD
Tablet
17
VITACARE FARMA
Angola
2
$18K
SYNCOM FORMULATIONS …
Tablet
18
LIYANA TRADE MARKETING PVT LTD
Nepal
3
$17K
SUN PHARMACEUTICAL I…
Tablet, Suspension
19
ALLA AAMIN PHARMACEUTICALS CO
Somalia
2
$16K
BAL PHARMA LTD
Tablet
20
GITTOES PHARMACEUTICALS LTD
Kenya
2
$11K
AGOG PHARMA LTD
Suspension, Tablet
21
DURBINPLC
United Kingdom
1
$11K
MICRO LABS LTD
Tablet
22
PLANET PHARMA SA
France
2
$11K
AJANTA PHARMA LTD
Suspension, Kit
23
THE MEDICAL EXPORT GROUP BV
Netherlands
1
$9K
MICRO LABS LTD
Tablet
24
AXENIC TCHAD SARL
Cameroon
1
$9K
LILIUM INTERNATIONAL…
Suspension
25
AZUNIVET LLC
Azerbaijan
1
$8K
FLAGSHIP BIOTECH INT…
Tablet
26
PHARM -URGENCESB P
Cameroon
1
$8K
DEVLIFE CORP PVT LTD
Suspension
27
STE PRINCE PHARMA SARL
DR Congo
5
$8K
VIDACARE MEDICA PVT …
Tablet
28
FARMA SOLUTION SOCIEDAD ANONIMA
Guatemala
1
$6K
CAPLIN POINT LABORAT…
Suspension
29
AFRICA PHARMACY LIMITADA
Angola
1
$3K
SHALINA LABORATORIES…
Tablet
30
ZIOTIS INTERNATIONAL LTD
United Kingdom
1
$3K
SAI WORLD TRADE LINK…
concentrate
31
MACK PHARMACY
Sierra Leone
2
$3K
SYNCOM FORMULATIONS …
Tablet
32
IMPERIAL MEDICAL SOLUTIONS FZE
United Arab Emirates
1
$2K
MACLEODS PHARMACEUTI…
Suspension
33
JALIM BAH INVESTMENT
Sierra Leone
1
$2K
NOVASIS HEALTHCARE P…
Suspension
34
MEDAF PHARMACY SURL
Cameroon
1
$2K
SHALINA LABORATORIES…
Suspension
35
HYFLEX COMERCIO GERAL SU LDA
Angola
1
$1K
ZENKO LIFE SCIENCE LLP
Powder
36
GENEX SU LDA
Angola
2
$119.43
SANGEETA PHARMA
Tablet
37
DWIGHT HUTSON
Antigua and Barbuda
2
$107.94
AASHIRWAD PHARMA INT…
Tablet
38
LIFELINE PHARMACEUTICALS OF
Lesotho
1
$69.88
NUMED PHARMA DISTRIB…
Kit
39
CAREWELL PHARMACY (PTY)LTD
Seychelles
2
$11.81
CHEMSELECT PVT LTD
Suspension, Tablet
40
THE MASTER OF X PRESS GODAVARI
Netherlands
1
$10.79
3CUBE MEDICARE PVT LTD
Tablet
41
MIOT INTERNATIONAL{SC) (PTY) LIMITE
Seychelles
1
$9.02
MIOT MEDICAL SUPPLIE…
Tablet
42
MR PRO DELIVERY LTD
Mauritius
1
$5.74
TULIP LAB PVT LTD
Tablet
43
THE MASTER OF GH ANGELOU SHIP SPA
South Korea
1
$4.41
3CUBE MEDICARE PVT LTD
Tablet
44
EMIRATES POST GROUP
United Arab Emirates
3
$1.61
FALCON TRANSGLOBAL
Tablet
45
EMIRATES POST COMPANY
United Arab Emirates
3
$0.998
DERMA MEDICINE POINT
Tablet
This report covers 114 2025-Q4 Sulfamethoxazole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/sulfamethoxazole
Talk to our trade analyst
Need a custom sulfamethoxazole report or a deeper dive into any market? Our team is ready.